Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

"This is an area in which we haven't had something we felt hopeful about in a while," professor Joseph Schacht said.

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, ...

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

What do many kids like most about the coming of a new year? The fireworks. Investors don't mind seeing some fireworks in ...

Exercise includes cardio and strength training, which together support heart health, healthy blood sugar levels, and weight ...

Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...